Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.62 -2.21 (-2.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Share-based Compensation (2010 - 2026)

Updated

Ani Pharmaceuticals' Share-based Compensation was $11.41 million in Q2 2026, up 18.8% from $9.6 million a year earlier and up 11.9% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Share-based Compensation (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ani Pharmaceuticals' Share-based Compensation was $41.06 million through Jun 30, 2026, up 24.4% year-over-year; for FY2025, it was $37.93 million, up 29.3% from FY2024.

  • Share-based Compensation has now increased for four consecutive years, with a five-year compound annual growth rate of 24.0% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $29.34 million in FY2024 (+42.1%), $20.65 million in FY2023 (+41.5%), $14.6 million in FY2022 (+39.2%) and $10.49 million in FY2021 (-18.9%).
  • The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q3 2010.
  • Compared with a year earlier, Share-based Compensation has increased for 20 straight quarters, with growth averaging 26.8% over the last eight quarters.
  • The year-over-year growth in Share-based Compensation has ranged between 14.9% (Q1 2026) and 73.2% (Q1 2022) over the last five years.
  • Per Business Quant data, ANIP's Share-based Compensation in the three quarters before Q2 2026 was $10.19 million (Q1 2026), $9.77 million (Q4 2025) and $9.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Ani Pharmaceuticals 1.78 Bn 565.34 Mn 165.89 Mn 11.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.41 Mn
Mar 31, 2026 10.19 Mn
Dec 31, 2025 9.77 Mn
Sep 30, 2025 9.69 Mn
Jun 30, 2025 9.60 Mn
Mar 31, 2025 8.87 Mn
Dec 31, 2024 7.06 Mn
Sep 30, 2024 7.49 Mn
Jun 30, 2024 7.86 Mn
Mar 31, 2024 6.93 Mn
Dec 31, 2023 5.62 Mn
Sep 30, 2023 5.44 Mn
Jun 30, 2023 5.25 Mn
Mar 31, 2023 4.34 Mn
Dec 31, 2022 3.74 Mn
Sep 30, 2022 3.87 Mn
Jun 30, 2022 3.76 Mn
Mar 31, 2022 3.24 Mn
Dec 31, 2021 2.97 Mn
Sep 30, 2021 2.81 Mn
API Access

Ani Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ANIP&period=max&api_key=YOUR_API_KEY